Briefs: Concord Biotech and Neuland Laboratories
Drug Approval

Briefs: Concord Biotech and Neuland Laboratories

The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483

  • By IPP Bureau | March 23, 2024

Concord Biotech receives EUGMP certificate for Dholka facility

Government of Upper Franconia has Issued Certificate of Good Manufacturing Practices (EUGMP) of our Unit I (API facility) of Concord Biotech Limited, located at Trasad Road, Dholka - 382225 in Ahmedabad, Gujarat. The certificate is issued for the product "Tacrolimus Premix 20%"

Neuland Laboratories Unit 1 successfully completes USFDA inspection

Neuland Laboratories Limited has announced that the United States Food and Drug Administration (US FDA) has inspected its Unit 1 manufacturing facility at Bonthapally, Hyderabad from 18th to 22nd of March 2024.  The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483.

Upcoming E-conference

Other Related stories

Startup

Digitization